Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)

Phase 2 Completed 29 enrolled Hoffmann-La Roche

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the efficacy and safety of 10 mg of oral administration balovaptan once a day (QD) compared with matching placebo in adults with PTSD.

Timeline

Start: 2022-08-02
Primary completion: 2023-10-05
Completion: 2023-10-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Balovaptan	Small molecule	10 mg	Oral

Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)

Summary

Timeline

Drugs

Indications